These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6988173)

  • 41. Effect of terbutaline sulphate in chronic "allergic" cough.
    Ellul-Micallef R
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):940-3. PubMed ID: 6412896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A long-term study of low-dose aerosolized terbutaline sulfate.
    Trautlein J; Allegra J; Gillin M
    J Clin Pharmacol; 1976 Jul; 16(7):361-6. PubMed ID: 947968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The clenbuterol treatment of patients with the chronic obstructive syndrome].
    Ionescu AA; Bistriceanu G; Bogdan M; Duţu S
    Pneumoftiziologia; 1995; 44(1-2):45-7. PubMed ID: 8721821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bronchodilator treatment for partially reversible chronic obstructive airways disease.
    Tandon MK; Kailis SG
    Thorax; 1991 Apr; 46(4):248-51. PubMed ID: 2038732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
    Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T
    Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction.
    Malolepszy J; Böszörményi Nagy G; Selroos O; Larsso P; Brander R
    Eur Respir J; 2001 Dec; 18(6):928-34. PubMed ID: 11829098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of prolonged administration of clenbuterol on airway reactivity and sweating in horses with inflammatory airway disease.
    Read JR; Boston RC; Abraham G; Bauquier SH; Soma LR; Nolen-Walston RD
    Am J Vet Res; 2012 Jan; 73(1):140-5. PubMed ID: 22204300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchodilating activity of oral clenbuterol in asthmatic children after single administration of different dosages.
    Boner AL; Bennati D; Castellani C; Sette L; Schiassi M
    Pediatr Pulmonol; 1987; 3(1):34-7. PubMed ID: 3588048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients suffering from a reversible bronchial obstruction.
    Maesen F; Smeets J; Polderman J
    Arzneimittelforschung; 1983; 33(12):1696-8. PubMed ID: 6365104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease.
    Shim CS; Williams MH
    Am J Med; 1983 Oct; 75(4):697-701. PubMed ID: 6624778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
    Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y
    Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of oral terbutaline and fenoterol in asthma.
    Miller WC; Rice DL
    Ann Allergy; 1980 Jan; 44(1):15-8. PubMed ID: 7352688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral terbutaline in chronic childhood asthma; effects related to plasma concentrations.
    Lönnerholm G; Foucard T; Lindström B
    Eur J Respir Dis Suppl; 1984; 134():205-10. PubMed ID: 6586481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease.
    Campbell M; Eliraz A; Johansson G; Tornling G; Nihlén U; Bengtsson T; Rabe KF
    Respir Med; 2005 Dec; 99(12):1511-20. PubMed ID: 16199148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.